| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |